Edition:
United States

Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

2.16USD
22 Sep 2017
Change (% chg)

$-0.02 (-0.92%)
Prev Close
$2.18
Open
$2.17
Day's High
$2.19
Day's Low
$2.14
Volume
130,396
Avg. Vol
235,738
52-wk High
$3.14
52-wk Low
$1.81

Latest Key Developments (Source: Significant Developments)

Geron Q2 loss per share $0.04
Wednesday, 9 Aug 2017 04:05pm EDT 

Aug 9 (Reuters) - Geron Corp :Geron Corporation reports second quarter 2017 financial results.Q2 loss per share $0.04.Q2 revenue $174,000.Q2 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.Q2 revenue view $255,000 -- Thomson Reuters I/B/E/S.  Full Article

Geron Q1 loss per share $0.05
Tuesday, 9 May 2017 04:05pm EDT 

May 9 (Reuters) - Geron Corp :Geron Corporation reports first quarter 2017 financial results and recent events.Q1 loss per share $0.05.Q1 revenue $537,000.Q1 revenue view $181,000 -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.05 -- Thomson Reuters I/B/E/S.  Full Article

Geron Corp and Janssen Research & Development LLC has completed second internal data reviews of Imerge and Imbark
Monday, 10 Apr 2017 07:30am EDT 

Geron Corp : Geron Corp - Janssen Research & Development, LLC has completed second internal data reviews of Imerge and Imbark . Geron Corp - For imerge, benefit/risk profile of Imetelstat in treated patients supports continued development in lower risk myelodysplastic syndromes . Geron-For Imbark, current results suggest clinical benefit, potential os benefit associated with Imetelstat treatment in relapsed or refractory myelofibrosis . Geron Corp - For Imerge, a data package and proposed trial design refinements are planned to be provided to FDA . Geron Corp - For Imbark, trial will continue unchanged to evaluate maturing efficacy and safety data, including an assessment of overall survival .Geron Corp - If part 2 of imerge is initiated, Geron expects this phase 3 stage of Imerge to be opened for patient enrollment in Q4 of 2017.  Full Article

Geron Corp says 2 parties to securities class action executed a stipulation and agreement of settlement to settle securities class action
Friday, 3 Mar 2017 07:45am EST 

Geron Corp : Geron corp says on March 2 parties to securities class action executed a stipulation and agreement of settlement to settle securities class action . Geron Corp says settlement does not constitute any admission of fault or wrongdoing by company or any of individual defendants . Geron Corp says expects $6.0 million of settlement amount to be paid by co's insurance providers and remaining $250,000 to be paid by co - SEC filing .Geron says in exchange for dismissal with prejudice of all claims against all defendants in lawsuit, co to settle securities class action for $6.25 million in cash.  Full Article

Geron qtrly loss per share $0.05
Wednesday, 1 Mar 2017 04:05pm EST 

Geron Corp : Geron Corporation reports fourth quarter and annual 2016 financial results .Qtrly loss per share $0.05.  Full Article

Geron Corp reports loss per share of $0.02
Thursday, 3 Nov 2016 08:26pm EDT 

Geron Corp : Geron Corporation reports third quarter 2016 financial results and recent events . Q3 loss per share $0.02 . Q3 revenue $5.1 million . Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 revenue view $156,000 -- Thomson Reuters I/B/E/S.  Full Article

Geron Corp reports loss per share of $0.02
Thursday, 3 Nov 2016 04:05pm EDT 

Geron Corp : Geron Corporation reports third quarter 2016 financial results and recent events . Q3 loss per share $0.02 . Q3 revenue $5.1 million . Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 revenue view $156,000 -- Thomson Reuters I/B/E/S.  Full Article

Geron Corp Q2 loss per share $0.05
Wednesday, 3 Aug 2016 04:05pm EDT 

Geron Corp : Q2 loss per share $0.05 . Q2 revenue $211,000 . Geron corporation reports second quarter 2016 financial results and recent events . Q2 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S .Q2 revenue view $302,000 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Geron Q2 loss per share $0.04

* Geron Corporation reports second quarter 2017 financial results